BOARD AND MANAGEMENT

Chair – Nomination Committee
Member – Investment and Capital Committee, People and Remuneration Committee

Mike was appointed a director in May 2017 and Chair effective 1 October 2020. He has more than 30 years of experience in financial services, predominantly in Australia and Asia.

Relevant other directorships:

• Chair – QBE Insurance Group Limited (since Mar 2020) and director (since Nov 2016)
• Director – Scentre Group Limited (since April 2020)

Relevant former directorships/executive roles:

• Managing Director and Chief Executive Officer (Nov 2007 to Nov 2015) – Insurance Australia Group
• Managing Director and Chief Executive Officer – Promina Group Limited
• Managing Director – Tyndall Australia Limited
  Acting Chief Executive Officer (Apr 2018 to Dec 2018)
• Executive Chairman (Apr 2018 to June 2018) and Director (Sept 2016 to Feb 2020) – AMP Limited
• Director – Maple-Brown Abbott Limited; Alinta Limited; The Geneva Association; The Australian Business and Community Network

David has been Chief Executive Officer since May 2021. He has 30 years of strategy and innovation, customer and commercial, and operational experience across Australia, Asia and the UK, including previous work in the consulting and financial services industries.

David joined Medibank in 2014 as Chief Operating Officer and then Group Executive – Chief Customer Officer from September 2016, responsible for the Medibank and ahm Health Insurance and Diversified financial businesses. He was appointed Acting Chief Executive Officer between April 2016 and June 2016. 

Relevant other directorships: 

• Member – Council of Management for the International Federation of Health Plans
• Member – Australian Private Health Chief Executive Officer Forum (CEO Forum)

Relevant former directorships/executive roles: 

• Group Chief Commercial Officer (2008-2014) – Jetstar
• Director – Jetstar Pacific (Vietnam); Jetstar Hong Kong; NewStar airline group (Singapore)
• Non-Executive Director – Luxury Escapes (2017-2020)

Chair – People and Remuneration Committee
Member – Risk Management Committee, Nomination Committee

Tracey was appointed a director in August 2017. She has extensive experience in the health services sector, with strong commercial, strategy, and change leadership skills. 

Relevant other directorships: 

• Director – EBOS Group Limited (since July 2021); Nanosonics Limited (since September 2023)

Relevant former directorships/executive roles: 

• Chair – Accident Compensation Corporation
• Director – Abano Healthcare Group; National Institute of Water and Atmospheric Research, NZ
• Chief Executive – Imperial College Healthcare NHS Trust UK
• Chief Executive – St Vincent’s Health Australia
• Chief Executive Officer of a number of other healthcare groups in Australia

Chair – Audit Committee
Member – Risk Management Committee, Nomination Committee

Gerard was appointed a director in May 2021. A partner of EY until September 2020, Gerard held a number of senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner-Markets; Oceania Managing Partner-Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles Gerard advised organisations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial and financial due diligence. 

Relevant other directorships: 

• Chair – Melbourne Archdiocese Catholic Schools; Gillespie Family Council & Gillespie Family Foundation
• Director – Nanosonics Limited; Melbourne Prize Trust

Relevant former directorships/executive roles: 

• Director and Chair (Finance & Audit Committee) – Mercy Health & Aged Care
• Director and member of the Finance Committee; Berry Street Victoria
• Director and Co-Deputy Chair – Committee for Melbourne

Member – Investment and Capital Committee, People and Remuneration Committee

Peter was appointed a director in March 2022. He has over 25 years of corporate experience and is highly respected in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes key roles at companies with a strong consumer and technology focus.

Relevant other directorships: 

• Director – Super Retail Group Limited (since December 2017)
• Governor – WWF Australia

Relevant former directorships/executive roles: 

• Director – iCar Asia Limited (July 2017 to May 2022)
• Managing Director international division (and concurrently Chair of Seek’s subsidiary, Zhaopin) – Seek Limited
• Director – ME Bank; IDP Education Ltd
• Senior Executive – Yahoo! Australia and Southeast Asia

Chair – Risk Management Committee
Member – Audit Committee, Nomination Committee

David was appointed a director in March 2014. He practised as a commercial lawyer for over 40 years. During that time, he held a variety of leadership positions at Clayton Utz culminating in the role of Chief Executive Partner for 9 years. In this role, David had responsibility and accountability for leadership and transformation, strategy, finance, stakeholder engagement, and governance, including risk management. During David’s tenure as Chief Executive Partner, Clayton Utz entrenched itself as a first-class top tier commercial law firm. David also chaired the Medibank Privatisation Committee which operated during 2014 in preparation for the privatisation process.

Relevant other directorships: 

• Chair – BDO Group Holdings Limited and member of its Risk Management Committee

Relevant former directorships/executive roles: 

• Director – The Global Foundation and Chair of the Audit Committee; PayGroup Limited (Nov 2017 to Nov 2022); Grocon Funds Management Group; the Hilco Group; UBS Grocon Real Estate Investment Management Australia Pty Limited
• Advisory Board Member – Chase Corporate Advisory

Member – Audit Committee, People and Remuneration Committee

Kathryn was appointed a director in March 2022. She is a highly respected director and Chair with significant, wide-ranging senior commercial and operational experience. 

Relevant other directorships: 

• Chair – Watertrust Australia Ltd; Breast Cancer Network Australia
• Director – National Australia Bank Ltd (since Dec 2019); Djerriwarrh Investments Ltd (since May 2014); The Myer Foundation, Grattan Institute and the Champions of Change Coalition

Relevant former directorships/executive roles: 

• Chair – CSIRO (October 2021 to March 2025) and director (August 2018 to October 2021)
• Chair – Boral Limited (July 2018 to July 2021) and director (September 2014 to July 2021)
• Chair – Parks Victoria; Melbourne Recital Centre
• President – Chief Executive Women (CEW)
• Director – Incitec Pivot Limited (April 2014 to December 2019)
• Board member – Reserve Bank of Australia (2013 to 2018); Australian Centre for Innovation

Chair – Investment and Capital Committee
Member – Risk Management Committee, Nomination Committee

Linda was appointed a director in March 2014. She has more than 30 years of experience as a senior executive and director in banking, insurance and funds management in Australia, New Zealand and the United States.

Relevant other directorships: 

• Chair – Royal Melbourne Hospital
• Director – Inghams Group Limited (since Nov 2016); Museums Victoria Board

Relevant former directorships/executive roles: 

• Chair – Japara Healthcare Ltd (Mar 2014 to Nov 2021)
• Chair – Healthscope Ltd (2008 to 2010) and director (2002 to 2008)
• Director – Fairfax Media Limited; Sigma Pharmaceuticals Limited

Member – Audit Committee, Risk Management Committee

Jay was appointed a director in March 2024. He has had a distinguished career in public office with expertise across a wide range of public policy areas including reform of social services.

Premier of South Australia for more than 6 years, Jay was elected to Parliament in 2002, serving 16 years in a diverse range of portfolios including treasury, state development, education, Aboriginal affairs and the environment. Prior to this, he practised law, specialising in employment law. Jay leads a democracy initiative within the Susan McKinnon Foundation. He is also an ambassador for Reggio Children.

Relevant other directorships: 

• Chair – Leeuwin Ocean Adventure Foundation
• Director – Keystart WA; Infrastructure WA; Coaxial Foundation; Susan McKinnon Foundation
• Member – Council of the National Gallery of Australia

• Kylie is a registered Psychologist, specialising in organisational psychology and has been a member of the executive team since 2013. Kylie is responsible for leading key people functions, including culture, capability, performance, payroll, reward, diversity & inclusion, talent engagement, health, safety & wellbeing and workplace relations. She also leads the sustainability agenda across the group, as well as community and spaces.
• Kylie began her career in consulting and prior to joining Medibank in 2010 held senior positions with NAB.

Relevant directorships: 

• Non-executive director – Royal Melbourne Hospital and Basketball Victoria 
• Director (previous) – Rugby Victoria

• Rob is responsible for accelerating our growth in health through the development of digitally-led health products and services for our customers and the community. He has been a member of the executive leadership team since June 2021.
• Rob was previously accountable for growing and sustaining the Medibank and ahm insurance businesses, including oversight for our operational and customer-facing teams. Prior to that he led the ahm business.
• Rob has extensive experience in entrepreneurial leadership, as well as high-growth consumer brands. Before joining Medibank, Rob was the CEO of multi award-winning hardware/software business, Billy. He has also held commercial leadership roles at Jetstar and Qantas, and was the CEO of the travel booking engine, Jetsetter, which he sold to Tripadvisor.

• Tom is responsible for risk and compliance across Medibank. He has been a member of the executive leadership team since July 2024.
• Since joining Medibank in 2006, Tom has held a range of finance roles and worked closely with the financial operations side of the Health Insurance business. Tom also oversaw the establishment of the Medibank Uplift Program in 2023, focusing on managing our approach to information security risk.
• Prior to Medibank, Tom spent 11 years at Deloitte, working for five years with private business clients and six years in management consulting across a number of industries including health insurance.

• Milosh is responsible for the Medibank and ahm brands including marketing, customer channels, customer portfolios, member health programs, Live Better, provider partnerships and diversified insurance. He has been a member of the executive leadership team since June 2021.
• Milosh joined Medibank in 2016 and has held a number of roles leading customer strategy, commercial transformation, product innovation and portfolio management, strategic partnerships and AI.
• Milosh has extensive experience leading customer focused and data driven transformations across health, media and telecommunications industries, including proposition innovation and new business growth. Prior to joining Medibank, Milosh held senior roles at SEEK and McKinsey & Company.

Relevant directorships: 

• Director – Private Healthcare Australia Limited

• Mei is responsible for leading the customer trust, legal and governance functions including regulatory affairs. Mei also holds the positions of Group General Counsel and Company Secretary. She has been a member of the executive leadership team since 2016.
• Mei has more than 25 years of experience as a senior in-house legal adviser for multinational and international companies as well as private practice. Prior to joining Medibank, she was the General Counsel and Company Secretary for the Asia Pacific region at Cummins Inc. and also held senior legal positions at Coles Myer Ltd and Southcorp Limited. Mei started her legal career at Arnold Bloch Leibler and also worked as a Senior Associate at Minter Ellison. 

Relevant directorships:

• Director and President (immediate past) – Association of Corporate Counsel (ACC) Australia
• Chair (former) – ACC GC100
• Member – Chief Executive Women

• Rob oversees Medibank’s growing role as a health services provider. He is responsible for the health services we deliver on behalf of our health insurance business as well as to customers in the private and public sector. These include prevention programs, telehealth, in-home care, and our healthcare investments across short stay hospitals and primary care. He has been a member of the executive leadership team since November 2023.
• Rob joined Medibank in 2022 as Amplar Health’s Chief Commercial Officer, responsible for evolving its health services strategy including our focus on virtual health and growing our prevention services.
• Prior to joining Medibank, Rob held senior roles in Private Equity and at leading pharmaceutical company, GSK PLC. Most recently Rob was CEO and Managing Director at MedAdvisor Ltd, a technology-led medication adherence company operating in Australia, US and the UK.

Relevant directorships: 

• Director – Adeney Private Hospital
• Chair – Myhealth Medical Group

• Mark is responsible for the finance, actuarial, treasury, internal audit, investor relations and procurement functions across Medibank as well as group strategy and M&A. He has been a member of the executive leadership team since January 2017.
• Mark has more than 25 years of global experience across the financial services, healthcare, pharmaceuticals and logistics sectors. Before joining Medibank, Mark held senior financial and group development roles at NAB and prior to that he was responsible for strategy, M&A and investor relations for the former ASX listed healthcare, pharmaceuticals and logistics company Mayne Group.

Relevant directorships: 

• Director – Myhealth Medical Group, Integrated Mental Health, East Sydney Private Hospital and Royal Children’s Hospital Melbourne

• Meaghan is responsible for government and industry relations, health stakeholders, health policy, reputation and external communications. Meaghan joined Medibank in 2016 leading the External Affairs function and previously held the role of Senior Executive – Policy, Advocacy and Reputation. She has been a member of the executive leadership team since July 2023.
• Meaghan is a corporate affairs professional with a career spanning more than 20 years in sport, politics and ASX listed entities. In these roles, she has been responsible for driving the external agenda for organisations through media management, government relations, campaign and stakeholder management, employee engagement and public affairs research.
• Prior to Medibank, Meaghan led Group Corporate Communications for NAB, responsible for communications on mergers and acquisitions, customer pricing strategy, financial reporting and issues management.

• Felicia leads the Data & Technology team, responsible for our technology, information security, data, digital and core platforms.
• She joined Medibank in February 2024 from AMP, where as Chief Technology Officer she played a pivotal role in developing their technology strategy and accelerating the adoption of digital and data technology across the group.
• Felicia has more than 28 years of experience in technology and transformation, including leading the technology services function at Australian Super, and establishing ANZ’s Digital Labs to prototype and test emerging technologies. She has also held senior roles at Microsoft, Deloitte, and Accenture.